SRC and plasma cell myeloma: We found that GAC 17:1 inhibited both constitutive and IL-6-inducible STAT3 activation in multiple myeloma cells along with the abrogation of c-Src and JAK2 activation and the induction of PTEN and SHP-1 proteins.